About Us
Real-time Quotes & News
Market Analysis
Trading Platform
Terms
Promotion
FAQ
Contact
繁
简
EN
繁
简
EN
Promotion
FAQ
Contact
Open Account
Contact Us

The U.S. Conference Board Consumer Current Conditions Index for February was 120, down from 113.7 in February.

2026-02-24

The U.S. Conference Board Consumer Current Conditions Index for February was 120, down from 113.7 in February.

Other News
2026-02-24

Integrated Circuits (Chips): 1. ASML unveils breakthrough in EUV light source technology, potentially increasing chip production by 50% by 2030. 2. SK denies media rumors, stating it has never discussed building a DRAM memory wafer fab in Japan. 3

Integrated Circuits (Chips): 1. ASML unveils breakthrough in EUV light source technology, potentially increasing chip production by 50% by 2030. 2. SK denies media rumors, stating it has never discussed building a DRAM memory wafer fab in Japan. 3. SK Chairman Chey Tae-won pledges to SK Hynix expand HBM production, pointing out the significant uncertainty AI brings to the market. Artificial Intelligence: 1. Honor will launch its first humanoid robot. 2. OpenAI adjusts its "Stargate" project strategy: postponing self-construction and shifting towards deeper cooperation with Oracle and SoftBank. 3. The Canadian government states that "all options are on the table" in dealing with OpenAI. The Canadian Minister of Artificial Intelligence will meet with the OpenAI security team on Tuesday. 4. Amazon: Will invest $12 billion in Louisiana to build its first data center campus. The project will create 540 full-time data center jobs and support 1,710 additional jobs. 5. Anthropic claims Claude Code can automate some of the modernization work of the Common Business Language (COBOL), causing IBM's stock price to plummet over 13% on Monday. Other: 1. Frontier Biotech: Reached an exclusive licensing agreement with GlaxoSmithKline. 2. US media: US Defense Secretary Hergsays will meet with Anthropic CEO Tuesday morning local time. 3. Novo Nordisk stated that in clinical trials, its canagliflozin (Cagrisema) failed to meet the efficacy criteria for non-inferiority to Eli Lilly's Tirzepatide.
2026-02-24

In an era of unrestrained sovereign debt issuance and persistent sticky inflation, preserving wealth from erosion has become the primary concern for every investor. Perhaps we can draw lessons from the investment philosophy of macro trading master Pa

In an era of unrestrained sovereign debt issuance and persistent sticky inflation, preserving wealth from erosion has become the primary concern for every investor. Perhaps we can draw lessons from the investment philosophy of macro trading master Paul Tudor Jones…
Open Account
Demo Account
Contact Us
About Us Real-time Quotes & News Market Analysis
 Trading Platform Market Analysis Promotion Terms Promotion FAQ Contact
Copyright © 2026 Aspire Global Company Limited. All Rights Reserved.
Terms of Use and Privacy
Disclaimer

Disclaimer: ASPIRE is not responsible for the content of any analysis, advice, comment, suggestion, research report or market data in this website and links to third-party websites or resources. All the information mentioned above only represents the view of corresponding author. ASPIRE cannot and does not warrant the accuracy, validity, timeliness or completeness of any such information. You should conduct individual assessments and other proper research to make their investment decisions. The materials and information contained in this website are provided for reference only and do not constitute or form an offer, invitation, solicitation or investment advice or recommendation to acquire or dispose of any investment products or services. The price of any financial instruments described in this website may fall as well as rise. Past performance should not be taken as an indication of future performance. The risk disclosure statements do not purport to disclose or discuss all of the risks and other significant aspects of any financial instruments mentioned in this website. You should make your own appraisal of the risk and should consult to the extent necessary your own legal, tax, financial or other professional advisers in respect of any financial instruments mentioned in this website prior to entering into any transaction.

Risk Warning: Leveraged Precious Metals trading on margin carries significant risks and is not suitable for all investors. Please be sure to make investments within your own tolerance after fully understand the risks involved.

Registered & Business Address: Room 1905-1906, 19/F, Eastern Commercial Centre, 395-399 Hennessy Road, Hong Kong

Aspire Global Company Limited is not available to provide services for the residents of certain jurisdictions such as Afghanistan, the United States of America, the Islamic Republic of Iran, North Korean.